Total Payments
$2,838
2024 Payments
$475.86
Companies
32
Transactions
134
Medicare Patients
4,264
Medicare Billing
$283,329

Payment Breakdown by Category

Food & Beverage$2,729 (96.2%)
Education$108.37 (3.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,729 132 96.2%
Education $108.37 2 3.8%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $413.80 29 $0 (2024)
PFIZER INC. $243.99 14 $0 (2024)
Boston Scientific Corporation $212.52 3 $0 (2020)
KARL STORZ Endoscopy-America $195.19 4 $0 (2018)
PROCEPT BioRobotics Corporation $189.08 1 $0 (2023)
Sumitomo Pharma America, Inc. $185.91 9 $0 (2024)
Merck Sharp & Dohme LLC $182.19 10 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $178.64 9 $0 (2024)
ABBVIE INC. $135.12 7 $0 (2024)
Janssen Biotech, Inc. $123.58 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $475.86 23 Sumitomo Pharma America, Inc. ($79.23)
2023 $840.79 35 PROCEPT BioRobotics Corporation ($189.08)
2022 $325.79 19 PFIZER INC. ($100.49)
2021 $13.40 1 PFIZER INC. ($13.40)
2020 $165.28 5 Boston Scientific Corporation ($127.02)
2019 $468.18 33 Astellas Pharma US Inc ($253.96)
2018 $548.45 18 KARL STORZ Endoscopy-America ($195.19)

All Payment Transactions

134 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/02/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $21.96 General
Category: ONCOLOGY
11/06/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $17.51 General
Category: Oncology
11/04/2024 Sagent Pharmaceuticals Glydo (Drug) Food and Beverage Cash or cash equivalent $18.65 General
Category: Topical local anesthetic
10/24/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $19.37 General
Category: Oncology
10/04/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $32.18 General
09/09/2024 Teleflex LLC UROLIFT (Device) Food and Beverage In-kind items and services $18.01 General
Category: INTERVENTIONAL UROLOGY
09/05/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Food and Beverage In-kind items and services $25.65 General
Category: ONCOLOGY
07/25/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.31 General
Category: Oncology
06/24/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $19.82 General
Category: ONCOLOGY
05/02/2024 Ethicon US, LLC Enseal (Device) Food and Beverage In-kind items and services $20.29 General
Category: Energy
05/01/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $20.96 General
Category: HORMONE THERAPY
04/27/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $25.77 General
Category: BOTOX THERAPEUTIC
04/23/2024 UROGEN PHARMA, INC. JELMYTO (Drug) Food and Beverage In-kind items and services $21.31 General
Category: UROTHELIAL CANCER
03/28/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $24.75 General
Category: Oncology
03/21/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $19.07 General
Category: Oncology
03/04/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $20.71 General
Category: HORMONE THERAPY
02/29/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $21.87 General
Category: Oncology
02/22/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.98 General
Category: BOTOX THERAPEUTIC
02/19/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $22.01 General
Category: ONCOLOGY
02/08/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $16.31 General
Category: ONCOLOGY
02/07/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $16.48 General
Category: HORMONE THERAPY
01/11/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $17.81 General
Category: ONCOLOGY
01/10/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $21.08 General
Category: HORMONE THERAPY
12/07/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $19.67 General
Category: ONCOLOGY
11/30/2023 Janssen Biotech, Inc. ERLEADA (Drug), AKEEGA Food and Beverage In-kind items and services $24.96 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 890 4,846 $179,062 $52,290
2022 12 818 3,796 $144,841 $43,480
2021 29 1,419 6,433 $322,843 $119,957
2020 27 1,137 5,896 $269,837 $67,602
Total Patients
4,264
Total Services
20,971
Medicare Billing
$283,329
Procedure Codes
83

All Medicare Procedures & Services

83 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 188 240 $53,760 $20,163 37.5%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 31 45 $33,750 $7,758 23.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 109 113 $16,950 $6,469 38.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 58 58 $21,460 $6,376 29.7%
74178 Ct scan of abdomen and pelvis before and after contrast Office 2023 18 19 $17,214 $3,662 21.3%
55700 Biopsy of prostate gland Office 2023 11 12 $9,600 $1,855 19.3%
76872 Ultrasound scan of pelvic region through rectum Office 2023 14 15 $5,175 $1,533 29.6%
51702 Simple insertion of temporary bladder tube Office 2023 15 23 $6,624 $1,058 16.0%
76775 Limited ultrasound scan behind abdominal cavity Office 2023 17 18 $4,140 $773.40 18.7%
81001 Manual urinalysis test with examination using microscope, automated Office 2023 129 174 $2,262 $538.03 23.8%
81003 Automated urinalysis test Office 2023 179 223 $1,784 $486.54 27.3%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 58 65 $2,665 $485.46 18.2%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 30 3,805 $1,522 $444.54 29.2%
74018 X-ray of abdomen, 1 view Office 2023 18 20 $1,340 $389.49 29.1%
74420 Imaging of urinary tract following injection of a contrast agent Facility 2023 15 16 $816.00 $298.24 36.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 164 199 $44,576 $16,148 36.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 123 136 $20,400 $8,121 39.8%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2022 30 39 $29,250 $6,795 23.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 53 53 $19,610 $5,951 30.3%
74178 Ct scan of abdomen and pelvis before and after contrast Office 2022 17 17 $15,402 $3,154 20.5%
76775 Limited ultrasound scan behind abdominal cavity Office 2022 21 24 $5,520 $841.62 15.2%
74018 X-ray of abdomen, 1 view Office 2022 23 27 $1,809 $576.83 31.9%
81001 Manual urinalysis test with examination using microscope, automated Office 2022 128 170 $2,210 $518.29 23.5%
81003 Automated urinalysis test Office 2022 166 198 $1,584 $434.36 27.4%
51798 Ultrasound measurement of bladder capacity after voiding Office 2022 53 64 $2,624 $430.94 16.4%

About Dr. Christopher Winter, MD

Dr. Christopher Winter, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982043824.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Winter, MD has received a total of $2,838 in payments from pharmaceutical and medical device companies, with $475.86 received in 2024. These payments were reported across 134 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,729).

As a Medicare-enrolled provider, Winter has provided services to 4,264 Medicare beneficiaries, totaling 20,971 services with total Medicare billing of $283,329. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.

Practice Information

Products in Payments

  • XTANDI (Drug) $338.33
  • MYRBETRIQ (Drug) $195.18
  • AQUABEAM ROBOTIC SYSTEM (Device) $189.08
  • Nubeqa (Drug) $156.99
  • KEYTRUDA (Biological) $156.54
  • ORGOVYX (Drug) $155.05
  • 09 PROMO FLEX-X FLEX URETEROSCOPE, 7.5F (Device) $137.77
  • REZUM (Device) $127.02
  • INTERSTIM (Device) $108.42
  • BOTOX (Biological) $101.37
  • JELMYTO (Drug) $87.64
  • ERECTILE DYSFUNCTION (Device) $85.50
  • ERLEADA (Drug) $64.49
  • Axumin (Drug) $59.66
  • XIAFLEX (Biological) $55.19
  • LYNPARZA (Drug) $46.34
  • GEMTESA (Drug) $43.12
  • AVEED (Biological) $41.38
  • PROVENGE (Drug) $40.38
  • LUPRON DEPOT (Drug) $33.75

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Greensboro